What is the main business of HI Orthotics?

The main business activity of HI Orthotics focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 27, 2022.

Where is the headquarters located?

The headquarters is located at: Aleje Jerozolimskie 89, 02-001 Warszawa.

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of $39,377 in 2025, which is an increase of 13.7% compared to 2024.

No, the company recorded a net loss of $8,598 in 2025. For comparison, in 2024 the loss was $14,768, meaning the company reduced its loss by 41.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under depreciation and amortization. This category amounted to $47,312 in 2025, representing 99% of all operating expenses.

HI Orthoticssp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-07-27

Share capital

10,000.00 PLN

Activity description

HI Orthotics supplies orthotic clinics with equipment and solutions that help people with leg weakness move safely. Its products include the ML1 knee joint, designed for quiet operation, safety and ease of use.

Registered address

Aleje Jerozolimskie 89/43, 02-001 Warszawa, Poland

Website

hiorthotics.com

Social media

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 7 days early.

202514/07/2026
202402/07/2025
202304/07/2024
202211/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 39.38kMedianUSD 73.26kAverageUSD 3.23m

Net profit

This companyUSD -8.60kMedianUSD 68.58AverageUSD 82.17k

Operating costs

This companyUSD 47.98kMedianUSD 75.78kAverageUSD 3.04m

Assets

This companyUSD 142.69kMedianUSD 119.88kAverageUSD 3.90m

Industry

Offer

Knee joints
Lamination kits
Orthotic equipment

Website technology

Website

WordPress

Authorized Representatives

Piotr Jerzy Laszczak – Management Board Member

Piotr Walaszek – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Piotr Jerzy Laszczakage 37	70	$945.43	35%
Medi Ventures sp. z o.o. + limited partnership	60	$810.37	30%
Piotr Walaszekage 39	70	$945.43	35%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-09-01.

ING Bank Śląski
48 1050 1025 1000 0091 5131 9986

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Aug 18, 2022	Aid for SME access to finance — aid for start-ups	$175.9K$175,864	Dyrektor Narodowego Centrum Badań i Rozwoju

Competitors

	Name	Revenue	Website
	Exomedissp. z o.o.	$26,633.41	exomedis.com
	ArthecS.A.	$10,911.16	arthec.eu

Change history

Date	Event
2022-11-21	Share capital increase (5,000.00 PLN → 10,000.00 PLN)
2022-07-27	Entered in the register

FAQ

Last updated: 2026-07-14